文献速递角膜与眼表疾病

供体组织预孵育VEGF细胞因子陷阱促进高危角膜移植存活

Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival.
PubMed 文献 · Br J Ophthalmol · 2021-11-22

该研究在小鼠高危角膜移植模型中,将供体角膜组织体外预孵育血管内皮生长因子(VEGF)细胞因子陷阱VEGFR1R2 24小时(对照为人IgG Fc),发现陷阱在术后至少2周存在于移植物并扩散至受体角膜,显著减少全角膜血管、淋巴管和巨噬细胞,改变引流淋巴结树突状细胞表型,并显著改善长期高危移植物存活。

要点

  • 供体角膜预孵育VEGFR1R2陷阱后,术后1周和2周全角膜血管、淋巴管和巨噬细胞显著减少(p<0.05)。
  • 引流淋巴结中CD11c+树突状细胞频率显著降低,CD200R+调节性树突状细胞显著增加(p<0.05)。
  • 长期高危角膜移植物存活显著改善(p<0.01)。

核心结论

  • 供体角膜组织预孵育VEGFR1R2细胞因子陷阱可显著促进后续高危角膜移植存活,为高危角膜移植开辟新治疗途径。

研究设计与样本

  • 小鼠高危角膜移植模型,供体组织术前预孵育VEGFR1R2细胞因子陷阱24小时,对照为人IgG Fc。
  • 术后第1、2、8周取角膜定量血管和淋巴管,取引流淋巴结分析树突状细胞和T细胞表型,并比较移植物存活。

主要发现

  • VEGFR1R2陷阱在术后至少2周存在于移植物中,并扩散至受体角膜。
  • 术后1周和2周,全角膜血管、淋巴管和巨噬细胞显著减少(p<0.05)。
  • 引流淋巴结中CD11c+树突状细胞频率显著降低,CD200R+调节性树突状细胞显著增加(p<0.05)。
  • 长期高危移植物存活显著改善(p<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Pathological neovascularisation of the host bed and the transplant itself is the main risk factor for graft rejection after corneal transplantation. This study aims to prevent this process by preincubation of the corneal donor tissue ex vivo with an antivascular endothelial growth factor (VEGF) cytokine trap blocking additional postsurgical hemangiogenesis and lymphangiogenesis to promote high-risk graft survival. METHODS: The donor tissue was preincubated with a VEGFR1R2 cytokine trap for 24 hours prior to murine high-risk corneal transplantation (human IgG Fc was used as the control). The distribution of VEGFR1R2 Trap in the cornea was investigated by immunohistochemistry. Corneas were excised to quantify the blood vessels (BVs) and lymphatic vessels (LVs) and draining lymph nodes (dLNs) were harvested to analyse the phenotype of dendritic cells (DCs) and T cells at week 1, 2 and 8 post-transplantation. Graft survival was compared between preincubation with VEGFR1R2 Trap and human IgG Fc in high-risk recipients. RESULTS: VEGFR1R2 Trap was present in the graft for at least 2 weeks after surgery and additionally diffused into the corneal recipient. BVs, LVs and macrophages in the whole cornea were significantly decreased 1-week and 2-week post-transplantation (p<0.05). In dLNs the frequency of CD11c+DCs was significantly reduced, whereas CD200R+ regulatory DCs were significantly increased after keratoplasty (p<0.05). Furthermore, long-term high-risk graft survival was significantly improved (p<0.01). CONCLUSIONS: Preincubation of corneal donor tissue with a VEGFR1R2 cytokine trap can significantly promote subsequent high-risk corneal transplant survival and thereby opens new treatment avenues for high-risk corneal transplantation.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhang W, Schönberg A, Hamdorf M, et al. Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival. Br J Ophthalmol. 2021. PMID: 34810177. doi:10.1136/bjophthalmol-2021-319745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。